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 2 
ABSTRACT 21 
Forty two Propionibacterium isolates were recovered from biopsy samples of the 22 
gastric mucosa of eight out of 12 healthy people. Of these, 41 were identified as belonging 23 
to Propionibacterium acnes; the remaining isolate was identified as belonging to 24 
Propionibacterium granulosum. Repetitive extragenic palindromic (REP)-PCR typing 25 
suggested that up to four strains might be present in the mucosa of the same individual. 26 
Sequence analysis of either recA, tly or camp5 genes of P. acnes isolates revealed two 27 
distinct phylogenetic lineages. As per the recA, most isolates belonged to type I, while the 28 
remainder of the isolates belonged to type II. Phenotypic analyses of representative isolates 29 
showed the different strains to have diverse biochemical properties. For example, large 30 
differences were seen in carbohydrate fermentation patterns, the results of qualitative and 31 
quantitative enzymatic profiling, and survival at acidic pH. In contrast, the patterns of 32 
resistance/susceptibility to a series of 16 antibiotics were rather similar, with no atypical 33 
resistances observed. The examined strains showed limited –if any– enzymatic activities 34 
that could be ultimately related to pathogenicity (lipolytic, proteolytic or haemolytic 35 
activity). This suggests that, in the gastric ecosystem, some Propionibacterium spp. 36 
genotypes and/or phenotypes can be considered true commensals. 37 
 38 
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1. Introduction 42 
Propionibacterium species are non-spore-forming, Gram-positive, anaerobic-43 
aerotolerant, pleomorphic rod-shaped bacteria, the fermentation end products of which 44 
include propionic acid. Besides the classical propionibacteria species from dairy products, 45 
Propionibacterium acnes, Propionibacterium granulosum, Propionibacterium avidum, 46 
Propionibacterium propionicum, and Propionibacterium lymphophilum are species 47 
typically found on the human skin and mucosa (Holland and Bojar, 2002), where they may 48 
exert either protective or harmful effects. However, in spite of this importance, scarce data 49 
are available for most species, except for P. acnes, the best known of the human-associated 50 
propionibacteria. Cutaneous Propionibacterium species might have genetic and 51 
biochemical similarity, occupying in consequence similar environments. Not surprisingly, 52 
thought at lower numbers, P. granulosum is usually found in close association with P. 53 
acnes (Dicksved et al. 2009; Saulnier et al. 2009). 54 
P. acnes predominates over other microorganisms inhabiting the pilosebaceous follicles 55 
(Miura et al. 2010), and is a member of the normal microbiota of the oral cavity, the 56 
nostrils, conjunctiva, the external ear canal, and the upper respiratory and intestinal tracts 57 
(Bik et al. 2006; Saulnier et al. 2009). It is usually regarded as a strict anaerobe, although it 58 
grows better under low oxygen tension (Gribbon et al. 1994). In fact, P. acnes can tolerate 59 
100% oxygen saturation, reflecting its ability to survive in a wide range of environments. P. 60 
acnes is well known for its role in acne vulgaris. Some authors suggest it contributes to the 61 
inflammatory phase of this condition (Dessinioti and Katsambas, 2010). Damage to host 62 
cells and tissues might occur via enzymes with degradative properties, including sialidases, 63 
neuraminidases, endoglycoceramidases and lipases (Brüggemann, 2005). The latter 64 
enzymes are thought to release free fatty acids, which in the skin irritate the follicular wall 65 
 4 
and surrounding dermis. Immunogenic factors of P. acnes such as surface determinants, 66 
heat shock proteins and chemoattractants might then trigger inflammation (Vowels et al. 67 
1995). P. acnes is also thought to be an opportunistic pathogen. It has been implicated in 68 
postoperative and device-related infections (Harris et al. 2005) as well as in a number of 69 
other conditions such as sarcoidosis, synovitis, pustulosis, endocarditis, endophthalmitis, 70 
hyperostosis and osteitis (Ishige et al. 2005; Leyden et al. 2001; Perry and Lambert, 2005). 71 
Infections generally occur in immunocompromised patients and newborns; they are less 72 
common in previously healthy individuals. However, evidence regarding the role of P. 73 
acnes as the causal agent of these diseases remains circumstantial. 74 
P. acnes is also well known for its immunomodulatory properties. High levels of anti-P. 75 
acnes antibodies have been reported in individuals with acne (Ashbee et al. 1997). The 76 
induction of pro-inflammatory cytokines, interleukin IL-1a, IL-1b, IL-8 and TNF- by P. 77 
acnes has also been reported (Vowels et al. 1995). The genome sequence of the species 78 
clearly shows it possesses many proteins involved in the ability to colonise and reside in 79 
human skin sites (Bruggemann et al. 2004), although no virulence determinants or 80 
pathogenicity factors have been identified. Thus, P. acnes is usually regarded as a disease-81 
causing organism, although some authors indicate it to be a harmless commensal (Eady and 82 
Ingham, 1994). 83 
The human stomach mucosa would appear to harbour a greater microbial diversity than 84 
originally anticipated (Bik et al. 2006; Monstein et al. 2000). Different species of 85 
lactobacilli and streptococci are among the majority populations seen (Bik et al. 2006; Ross 86 
et al. 2005). Although not among the dominant gastric microorganisms, Propionibacterium 87 
spp. has also been revealed by different culture-independent approaches (Dicksved et al. 88 
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2009; Monstein et al. 2000). Selected strains of all these bacterial groups could be of 89 
greater interest than others of intestinal origin for the design and formulation of probiotics. 90 
Their notable resistance to acidic conditions might be of use in maintaining the bacterial 91 
viability of probiotics during storage, in improving bacterial survival through the gastric 92 
passage, and be advantageous in the formation of biofilms (Holmberg et al. 2009), a key 93 
factor in gastric and intestinal colonisation (FAO/WHO, 2002). 94 
This work reports the identification and genetic typing of Propionibacterium spp. 95 
strains isolated from the stomach of healthy adults. Phenotypic and biochemical tests were 96 
undertaken to characterize the gastric strains. In addition, activities related to pathogenicity 97 
and resistance to antibiotics were also sought to assess their potential to cause harm. 98 
 99 
 100 
2. Material and Methods 101 
 102 
2.1. Sampling, media and culture conditions 103 
Gastric biopsies were aseptically collected from 12 healthy individuals undergoing 104 
routine upper gastrointestinal endoscopy by using an Olympus GIF-Q0165 gastroscope 105 
(Olympus Corporation, Tokyo, Japan) and a large (8 Fr) single-use, sterile biopsy forceps 106 
with a central bayonet (Boston Scientific Corporatin, Natick, USA). Before exploration, the 107 
gastroscope was washed and disinfected by immersion in a detergent solution with 108 
proteolytic enzymes (at 7%) and glutaraldehyde (at 2%). Biopsy samples were collected in 109 
sterile containers with a reduced saline solution (0.9% NaCl, 0.1% peptone, 0.1% Tween 110 
80, and 0.02% cysteine) and transported to the laboratory in less than two hours after 111 
intervention. The biopsies were then washed several times in a phosphate buffered saline 112 
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(PBS) solution, drained, weighed, and thoroughly homogenized in Maximum Recovering 113 
Diluent (Scharlab, Barcelona, Spain). Dilutions of these samples were spread on agar plates 114 
containing the following media, MRS (Merck, Darmstadt, Germany) supplemented with 115 
0.25% cysteine (Merck) (MRSC), Columbia Blood medium containing 5% defibrinated 116 
horse blood (CB; Merck), and Brain Heart Infusion medium (BHI; Oxoid, Basingstoke , 117 
Hampshire, UK). All plates were incubated anaerobically in an anaerobic chamber 118 
(Mac500, Down Whitley Scientific, West Yorkshire, UK) at 37°C for up to 5 days. In order 119 
to rule out potential bacterial contamination the saline solution used to transport biopsy 120 
samples was spread on the same media. Non-inoculated plates, used as a second negative 121 
control, were also incubated in the same conditions. 122 
 123 
2.2. Identification and genotyping of isolates 124 
Visible colonies were selected, purified by subculturing on the same medium and 125 
identified at the species level by a combination of amplified ribosomal DNA restriction 126 
analysis (ARDRA) and sequencing of the 16S rRNA amplicons. 127 
Total genomic DNA from isolates was purified from overnight cultures using the 128 
GenElute
TM
 Bacterial Genomic DNA kit (Sigma-Aldrich, St. Louis, MO, USA) following 129 
the manufacturer’s recommendations. Electrophoresis was performed in 1% agarose gels, 130 
and the DNA visualised by UV light after staining with ethidium bromide (0.5 g ml-1). 131 
For ARDRA, the 16S rRNA genes were almost completely amplified by the polymerase 132 
chain reaction (PCR) technique using the universal primers 27F (5’–133 
AGAGTTTGATCCTGGCTCAG–3’) and 1492R (5’–GGTTACCTTGTTACGACTT–3’), 134 
and a 2 x Taq Master Mix (Ampliqon, Skovlunde, Denmark). Amplicons were purified 135 
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using GenElute
TM
 PCR Clean-Up columns (Sigma-Aldrich), digested with the restriction 136 
enzymes HaeIII and HinfI (Fermentas, Vilnius, Lithuania), and electrophoresed as above. 137 
When required, amplicons were sequenced by cycle extension in an ABI 373 DNA 138 
sequencer (Applied Biosystems, Foster City, CA, USA). Sequences were compared to 139 
those in the GenBank database using the BLASTN program 140 
(http://www.ncbi.nlm.nih.gov/BLAST/), and to those held by the Ribosomal Database 141 
Project (http://rdp.cme.msu.edu/index.jsp).  142 
All isolates were genotyped by repetitive extragenic palindromic (REP)-PCR 143 
fingerprinting using primer BoxA2-R (5’–ACGTGGTTTGAAGAGATTTTCG–3’), as 144 
reported by Koeuth et al. (1995). Reproducibility studies of the REP-PCR technique 145 
showed a percentage of similarity of around 85%. Similarity of the patterns was expressed 146 
using Sorensen’s correlation coefficient after clustering by the unweighted pair group 147 
method using arithmetic averages (UPGMA). Analysis of the recA gene with primers PAR-148 
1 (5’–AGCTCGGTGGGGTTCGCTCATC–3’) and PAR-2 (5’–149 
GCTTCCTCATACCACTGGTCATC–3’) was performed to assign the P. acnes strains to 150 
type I or type II, as reported by McDowell et al. (2005). Additionally, DNA sequence 151 
analysis of the two putative virulence genes tly and camp5 was conducted using 152 
oligonucleotides and PCR conditions as previously described by McDowell et al. (2005) 153 
and Valanne et al. (2005), respectively. Sequences were compared to each other and to 154 
those deposited in the GenBank database. Similarity analysis was performed with the 155 
Neighbor-Joining algorithm using the program MEGA 4 (Tamura et al. 2007). For 156 
comparative purposes, representative published sequences from different genetic divisions 157 
associated with both health and infections (Lomholt and Kilian, 2010) were also included. 158 
 159 
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2.3. Fermentation of carbohydrates 160 
Carbohydrate fermentation profiles of the different strains were established using the 161 
commercial API 50 CH system (bioMérieux, Marcy l’Etoile, France) following the 162 
manufacturer’s instructions. 163 
 164 
2.4. Enzymatic activities. 165 
Enzyme activities were assessed using the semiquantitative APIZYM system 166 
(bioMérieux). Sixty five millilitres of a cellular suspension corresponding to McFarland 167 
standard 5 were inoculated into each well of the API-ZYM strips, incubated for 4 h under 168 
anaerobic conditions at 37°C, and developed as recommended. Activities were expressed as 169 
nmol of substrate hydrolysed under the assay conditions. 170 
 171 
2.5. Acid resistance 172 
The ability of the strains to survive under acidic conditions was assessed through 173 
exposure of the cells to an acidified solution. Changes on the viability of cell suspensions 174 
(10
8
 cells mL
-1
) in sterile saline solution (0.5% NaCl) acidified with HCl to pHs ranging 175 
from 2.0 to 5.0 were determined by plate counting on MRSC agar after incubation at 37°C 176 
for 90 min. 177 
 178 
2.6. Antibiotic resistance/susceptibility profiles. 179 
Minimum inhibitory concentrations (MICs) were determined by microdilution in 180 
VetMIC
TM
 plates for lactic acid bacteria (National Veterinary Institute of Sweden, Uppsala, 181 
Sweden) containing two-fold serial dilutions of 16 antibiotics. Colonies grown on MRSC 182 
agar plates were suspended in 2 mL of sterile saline (Oxoid) to obtain a density 183 
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corresponding to McFarland standard 2. This suspension was further diluted 1:15 with 184 
Mueller-Hinton medium (Oxoid) containing 0.5% glucose. One hundred microlitres of this 185 
were added to each well of the VetMIC
TM
 plate, and the plates incubated at 37ºC for 48-72 186 
h. MICs were defined as the lowest antibiotic concentration at which no visual growth 187 
(pellet at the bottom of the well) was observed. 188 
 189 
2.7. Presence of virulence factors 190 
To determine the pathogenic potential of the strains, the presence of putative 191 
virulence-related traits was investigated using classical procedures. The production of 192 
haemolysins was analysed by plate assays on CB agar. The presence of haemolysis is 193 
indicated by the formation of clear zones surrounding the colonies. Staphylococcus aureus 194 
CECT 4520
T
 (Colección Española de Cultivos Tipo, Valencia, Spain) was used as a 195 
positive control. The possible interaction of pore-forming Christie-Atkins-Much-Peterson 196 
(CAMP) factors from the P. acnes strains with S. aureus sphingomyelinase C was tested as 197 
previously described (Valanne et al. 2005) using CB agar plates employing the S. aureus 198 
CECT 4520
T
 strain as an indicator. DNase activity was assayed on DNase agar plates 199 
(Merck). Proteolytic activity was determined on RCM plates containing 3% skimmed-milk 200 
powder (Scharlab). Lipolytic activity was scored on Reinforced Clostridial Medium (RCM; 201 
Merck) plates supplemented with 10 g L
-1
 tributyrin (Sigma-Aldrich); all plates were 202 
incubated under anaerobiosis at 37ºC for 3-4 days, the time at which the diameter of the 203 
clearing zone was measured. The production of urease was examined by growing the 204 
strains in urease test broth consisting of RCM supplemented with urea (20g L
-1
) and phenol 205 
red (0.01g L
-1
) (Sigma-Aldrich). Urease production was indicated by the change in the 206 
phenol red indicator. 207 
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 209 
3. Results 210 
Viable bacteria of different species were recovered from the MRSC, CB and BHI agar 211 
plates for 10 of the 12 stomach mucosa samples examined. Counts ranged from 1x10
2
 to 212 
1x10
5
 colony forming units (cfu) per gram of mucosa. Representative isolates from all 213 
plates were purified by subculturing and subjected to a polyphasic identification system; the 214 
latter included ARDRA profiling, the sequencing of the 16S rRNA gene, and the 215 
comparison of the sequences against those in databases. Propionibacterium spp. isolates 216 
were recovered in the different media from the mucosa of eight individuals. Surprisingly, of 217 
the 42 isolates identified as Propionibacterium spp., 41 belonged to the species P. acnes. 218 
The remaining isolate was identified as a Propionibacterium granulosum. 219 
To assess the genetic diversity of the strains, all isolates were subjected to REP-PCR 220 
typing (Fig. 1). Statistical analysis of the results showed at least 12 genetic profiles with a 221 
similarity level below the percentage of reproducibility (85%) (Fig. 1); these can be 222 
considered to belong to different strains. Variability was observed even among isolates 223 
from the same individual, suggesting the presence of up to four strains in the stomach 224 
mucosa in some subjects. Representative isolates for these 12 profiles were subjected to a 225 
further genetic typing and to an exhaustive biochemical characterization to determine their 226 
genotypic, phenotypic and safety properties. Isolates with similar profiles but from different 227 
mucosa samples were also selected; thus, in total, 24 isolates were characterized, including 228 
the P. granulosum strain. The numbering of the strains, as represented in the tables and 229 
figures, includes species initials of the species, followed by the subject from which they 230 
were obtained and the code of the strain. Sequence analysis of recA, tly and camp5 genes 231 
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from the 23 P. acnes strains showed two consistent and distinct cluster groups (Fig. 2). The 232 
number of polymorphic sites varied depending on the gene. Respect to recA gene, 19 233 
strains harbour type I-specific sequences, while the remaining four (PA 1-3, PA 1-5, PA 6-234 
4, and PA 8-2) contained all type II-specific polymorphisms. Further, a transition mutation 235 
(A for G) at position 897 of the recA gene corresponding to type IB (McDowell et al. 236 
2008), was observed in nine of the 19 type I isolates. No type III-specific polymorphisms 237 
were recorded. Alignment of 777 bp of the tly genes revealed 22 differences in nucleotide 238 
positions and four allelic profiles, meanwhile in the camp5 gene 19 polymorphic sites and 239 
four different alleles were encountered. Sequences were aligned with those from 240 
representative strains of the recent work of Lomholt and Kilian (2010). This allowed us to 241 
compare the relatedness at the DNA level of the gastric P. acnes isolates with those from 242 
clinical (infections) and non-clinical (environmental) sources. As can be seen in the 243 
derivative phylogenetic trees (Fig. 2), the gastric strains were clearly divided into two 244 
groups, one of which appears to include reference strains isolated from the oral cavity (such 245 
as CCUG45436 and CCUG 50655) and corresponded to recA type II isolates. The second 246 
group belonged to recA type I and included 19 strains. This group was further split into two 247 
subgroups, containing each a similar number of isolates; one of these subgroups seemed to 248 
be related to acne-associated strains, which belonged to recA type IA. The other subgroup, 249 
identified as recA type IB, included environmental sequences, no particularly associated 250 
with skin infections (Lomholt and Kilian, 2010) 251 
The fermentation of 49 carbohydrates by the 24 selected strains was assayed using the 252 
API 50 CH system; Table 1 shows the results obtained. Rather wide phenotypic variation 253 
was observed among the different strains. Most fermented glycerol, D-arabinose, ribose, 254 
galactose, glucose, fructose, mannose, sorbitol, and N-acethyl-glucosamine, the utilization 255 
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of erythritol, adonitol, and mannitol was variable, and the fermentation of other 256 
carbohydrates was sporadic. Strengthening the genetic typing results, strains from the same 257 
individual showed different carbohydrate utilization profiles. Strains from different mucosa 258 
samples, however, sometimes showed identical or very similar profiles. It should be noted 259 
that the carbohydrate fermentation profiles do not always match those supposed specific for 260 
P. acnes recA type I or type II, the former –but not the latter– being able to ferment 261 
erythritol, ribose and sorbitol. 262 
Although less than that observed for the fermentation of carbohydrates, variability 263 
among the different strains was also seen in terms of the enzymatic activities assayed using 264 
the API-ZYM method (Table 2). In general, the strains showed a limited number of weak 265 
enzymatic activities. The majority showed acid phosphatase, naphtol-AS-BI-266 
phosphohydrolase and N-acetyl--glucosaminidase activities. Weak alkaline phosphatase, 267 
esterase (C4), esterase lipase (C8), -glucosidase and -mannosidase activities were also 268 
scored for some strains. 269 
The MIC values and antibiotic resistance-susceptibility patterns of 14 representative 270 
strains to 16 different antibiotics (all representatives of clinically important antimicrobial 271 
agents) were obtained by microdilution with the commercial VetMIC system. Table 3 272 
shows the results obtained. Contrary to that reported for clinical P. acnes strains, low 273 
resistance levels were observed for most antibiotics, and analysis of the distribution of 274 
MICs among the different strains suggests they all are susceptible to most antibiotics. 275 
Significant variation was only observed with respect to kanamycin, streptomycin, and 276 
trimethoprim. 277 
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Table 4 shows the results regarding the presence of putative virulence and/or 278 
pathogenicity factors in the 24 selected strains. None of the strains showed urease activity 279 
in urea broth with phenol red as an indicator. Furthermore, DNase activity in DNase agar 280 
plates was never detected. Some slight haemolysis was seen for just two strains of the recA 281 
type IB in CB agar. However, haemolysis by either P. acnes or S. aureus was not affected 282 
when these were cultivated close to one another, excluding the involvement of CAMP-like 283 
factors in this activity. The production of proteases was scant; only three strains showed 284 
small (although clear) hydrolysis halos on RCM plates with skimmed milk. In contrast 285 
nearly all isolates showed halos of lipolysis in agar plates with tributyrin. Notwithstanding, 286 
a few strains showed faint halos, two (PA 1-3, PA 6-4) did not grow in the assay medium, 287 
and one (PA 1-5), which did grow, showed no halo. The latter three strains belonged to 288 
recA type II. 289 
Species inhabiting the stomach ought to be highly resistant to acidic conditions. 290 
Analysis of this property was accomplished by incubating the strains in an acidic solution 291 
for 90 min and then plating. Counts were expressed as percentage survival compared to that 292 
recorded for control cells kept for the same time in a neutral solution. Strains maintained at 293 
pH 4.0 or higher showed no noticeable reduction in numbers, while they all were killed 294 
during treatment at pH 2.5 and 2.0. Fig. 3 shows large differences among the strains in the 295 
tolerance to pH 3.0. Reductions in counts of between 1 and 3 logarithmic units were 296 
commonly recorded at this pH. 297 
 298 
4. Discussion 299 
In this work, a series of 42 propionibacteria isolates from the stomach mucosa of healthy 300 
humans was identified by molecular methods, and then typed by REP-PCR. Of these, 41 301 
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isolates, corresponding to 23 different strains, were assigned to the species P. acnes and 302 
one to P. granulosum. These two species are usual members of the resident human 303 
microbiota in the sebaceous gland-rich areas of the skin (Miura et al. 2010), but also in 304 
conjunctiva, mouth, and intestines (Monstein et al. 2000; Saulnier et al. 2009). The P. 305 
acnes strains examined in this work mostly belonged to P. acnes recA type I, four belonged 306 
to type II and none to type III. Based on the fermentation of sugars or phenotypic profiling 307 
(Brüggemann, 2005; Higaki et al. 2000), the recA type II strains could not be distinguished 308 
from those of type I; this has been reported elsewhere (McDowell et al. 2005). Similar 309 
numbers of recA type IA and IB strains (as defined by McDowell et al. 2008) were found 310 
among the stomach isolates. These two groups corresponded with the clustering derived 311 
from tly and camp5 gene analysis (Fig. 2). Sequence analysis of tly and camp5 genes 312 
allowed us to allocate the gastric P. acnes strains in genetic divisions related or no with 313 
acne, following the recent study by Lomholt and Kilian (2010). According to these authors, 314 
the phylogenetic group termed as I-1a, that would include 10 of our strains, is strongly 315 
associated with acne, as compared to other divisions such as I-2 and II (which embraced 9 316 
and 4 of the gastric strains, respectively). Strains from the latter groups seem to be 317 
associated with healthy skin and opportunistic infections. In our study, division II 318 
corresponded with the recA type II group. However, in spite of this associations, the role of 319 
the different genotypes in health and disease has is far from conclusive (McDowell et al. 320 
2005; Lomholt and Kilian, 2010). 321 
Wide phenotypic and genetic diversity was found among the strains from the different 322 
individuals. Diversity was even encountered between isolates from the same subject, and up 323 
to four different strains were identified in the same mucosa sample. REP-PCR analysis 324 
matched in general with the clusters derived from sequencing analysis of recA, tly and 325 
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camp5 genes, showing recA type II strains a closer genetic relationship among themselves 326 
than to type I strains (Fig. 1). This confirms previous findings suggesting the existence of 327 
consistent distinct phylogenetic groups within this species, as revealed by the use of genetic 328 
typing methods such as random amplification of polymorphic DNA (RAPD) or multilocus 329 
sequence typing (MLST) (Perry et al. 2003; McDowell et al. 2005; Lomholt and Kilian, 330 
2010). 331 
A gradual worldwide increase in the prevalence of antibiotic resistance in P. acnes has 332 
been observed (Nord and Oprica, 2006). This has been attributed to the major role of 333 
antibiotics in acne therapy (Eady et al. 2003). In Europe, combined resistance to 334 
clindamycin and erythromycin is highly prevalent in P. acnes isolates from patients with 335 
acne –from 50 up to 91% (Ross et al. 2003). In contrast, resistance to tetracycline was 336 
shown to be in the 0-26% range. Not surprisingly, a strong correlation between antibiotic 337 
resistance and the prescribing patterns of different countries exists (Ross et al. 2003). 338 
However, strains of this work seem all to be free of atypical resistances, those encoded by 339 
dedicated genes (Ammor et al. 2007). Resistance to aminoglycosides (kanamycin, 340 
streptomycin) in Gram-positives is thought to be due to intrinsic mechanisms. In fact, the 341 
lack of cytochrome-mediated transport is though to be responsible for the strong resistance 342 
to aminoglycosides shown by most anaerobic and facultative bacteria (for a review see 343 
Ammor et al. 2007). Nevertheless, wide inter-strain variation in resistance levels to these 344 
antimicrobial agents, not linked to the presence or absence of dedicated antibiotic resistance 345 
genes, has been repeatedly reported in strains from different ecosystems (Ammor et al. 346 
2007). 347 
A vast array of degrading and host-interactive proteins located at the cell surface has 348 
recently been identified from the decoded genome of P. acnes (Brüggemann, 2005; 349 
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Brüggemann et al. 2004). Some of these proteins might be responsible for the phenotypic 350 
traits traditionally associated with pathogenesis (Dessinioti and Katsambas, 2010; Higaki et 351 
al. 2000). Production of CAMP factors and notable haemolytic and proteolytic activities 352 
that could ultimately be related with virulence were never detected by the classical methods 353 
used in this study. Moreover, clear differences in these properties were not scored among 354 
the different genetic types; only of note, was the scarce or absent lipolytic activity observed 355 
in three out of the four recA type II strains as compared with the rest of isolates. 356 
Furthermore, resistance to low pH (pH 3.0) was also shown to vary widely within the 357 
strains, independently of their genotype. Given that Propionibacterium species have been 358 
reported as a majority population in both healthy persons as well as in those suffering from 359 
many infections and inflammatory conditions (Eishi et al. 2010; Mihura et al. 2010), it 360 
would be of interest to determine the phenotypes and/or genotypes that render this 361 
bacterium either a commensal or pathogenic organism (Dessinioti and Katsambas, 2010; 362 
Mihura et al. 2010). The availability of the genome sequence of P. acnes, and soon that 363 
from other species, will allow post-genomic studies will help clarify whether the existing 364 
phenotypic properties are simply colonising traits or true virulence and pathogenic factors 365 
involved in the aetiology and pathogenesis of P. acnes-associated diseases. 366 
 367 
 368 
5. Conclusion 369 
Propionibacterium strains, mostly of the P. acnes species, were isolated as part of the 370 
dominant anaerobic cultivatable microbiota of mucosa samples from the human stomach. 371 
Wide phenotypic and genotypic diversity was encountered among the different strains, even 372 
among those isolates from the same individual. No clear pathogenic properties related to 373 
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the infectivity of this species were observed in the strains examined; however, genetic 374 
analyses proved some strains to be phylogenetically related with acne-associated strains. 375 
Together, the present results suggest propionibacteria species might be habitual, innocuous 376 
inhabitants of the gastric environment. Thought further research will be required to 377 
determine the precise role(s) of these bacteria in the gastric ecosystem it might be 378 
hypothesized about its contribution to the host health and well-being through their 379 
immunomodulatory activities. If this were the case, selected strains could be used as 380 
probiotics to counteract harmful bacteria such as Helicobacter pylori. 381 
 382 
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FIGURE LEGENDS 
 
Figure 1.- REP-PCR profiles of the 42 Propionibacterium spp. isolates obtained with 
primer BoxA2R. Below, dendogram of similarity of the typing patterns clustered by the 
UPGMA method using the Sorensen’s coefficient. Isolates having a coefficient higher than 
that of the reproducibility study (85%, indicated by a broken line) were considered to 
belong to different strains. Isolates having similar profiles but coming from gastric mucosa 
samples of different individuals were also selected for further characterization (indicated by 
a code of letters and numbers; see the text). Strains are all P. acnes except for PG 2-4, 
which is a P. granulosum. Strains of P. acnes type II are denoted by an asterisk. 
 
Figure 2.- Neighbour-joining cluster analysis of individual partial DNA sequences of the 
recA (A), tly (B) and camp5 (C) genes from 23 gastric Propionibacterium acnes strains. 
Published sequences of collection P. acnes strains (NCTC 10390 recA type II reference 
strain, NCTC 737 recA type I reference strain isolated from acne, CCUG 50480 from 
endocarditis, CCUG 32901 from blood, CCUG 27534 from urinary tract, CCUG 45436 
from oral cavity and CCUG 50655 from mandibular gland) were included for comparative 
purposes. Strains of P. acnes type II are denoted by an asterisk. 
 
Figure 3.- Survival of Propionibacterium spp. strains at pH 3.0 for 90 minutes. The results 
are expressed as the percentage of counts in MRSC as compared to a control dilution of the 
same strain maintained under the same conditions at pH 6.5. Strains are all P. acnes except 
for PG 2-4, which is a P. granulosum. Strains of P. acnes type II are denoted by an asterisk. 
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Table 1.- Carbohydrate utilization profiles of Propionibacterium strains from mucosa of the human stomach. 
 
Strain
a
 
Carbohydrate 
GLY ERY DAR RIB ADO GAL GLU FRU MNE SBE INO MAN SOR MDM MDG NAG SAL MAL LAC MEL SAC RAF GEN TUR TAG GNT 
                           
PA 1-1 + - + + + + + + + - - - + - - + - - - - - - - - - - 
PA 1-2 + - + + + + + + + - - - + - - + - - - - - - - - - - 
PA 1-3* + - + + - - + - - - - - - - - - - + - - - - - - - - 
PA 1-4 - - + + - - + - - - - - - - - + - - - - - - - - - - 
PA 1-5* + - + + - + + - + - - - - - - + - - - - - - - - - - 
PA 2-1 + - + + - + + + + - - - + - - + - - - - - - - - - - 
PA 2-2 + + + + + + + + + - + - + - - + - - - - - - - - - - 
PA 2-3 + - + + + - - - - - - - - - - + - - - - - - - - - - 
PG 2-4 + - + + - - + + - - - - - - - + - + - + + - - + - - 
PA 3-1 + - + + + + + + + - - - + - - + - - - - - - - - - - 
PA 3-2 - - - - - + + + - - - - - - - - - + + - + + - - - - 
PA 5-2 + + + + + + + + + - - + + - - + + + - - - - - - - - 
PA 6-1 + + + + + + + + + - - + + - - + - - - - - - - - - - 
PA 6-2 + - + + + + + + + - - - + - - + - - - - - - - - - - 
PA 6-3 + + + + + + + + + - + + + - - + - - + - + + - - + + 
PA 6-4* + - + + - - + - - - - - - - - + - - - - - - - - - - 
PA 6-5 + + + + - + + + + + - + + + + + - - + + - - + - - + 
PA 7-1 + - + + + + + + + - - - + - - + - - - - - - - - - - 
PA 7-2 + - + + - + + + + - - - + - - + - - - - - - - - - - 
PA 7-3 + - + + - + + + + - - - + - - + - - - - - - - - - - 
PA 8-1 - - + + - - - - - - - - - - - - - - - - - - - - - - 
PA 8-2* - - - + - - + - - - - - - - - - - - + - - - - - - - 
PA 8-3 + + + + + + + + + - - - + - - + - - - - - - - - - - 
PA 10-1 + + + + + + + + + - - - + - - + - - - - - - - - - - 
                           
 
Key of the compounds: GLY: glycerol; ERY: erythritol; DAR: D-arabinose; RIB: ribose; ADO: adonitol; GAL: galactose; GLU: glucose; FRU: fructose; MNE: mannose; SBE: sorbose; 
INO: inositol; MAN: mannitol; SOR: sorbitol; MDM: -methyl-D-mannoside; MDG: -methyl-D-glucoside; NAG: N-acethyl-glucosamine; SAL: salicin; MAL: maltose; LAC: lactose; 
MEL: melibiose; SAC: sucrose; RAF: raffinose; GEN: gentibiose; TUR: turanose; TAG: tagatose; GNT: gluconate. 
None of the strains fermented L-arabinose, D-xylose, L-xylose, -methyl-D-xyloside, rhamnose, dulcitol, amygdalin, arbutyn, esculin, cellobiose, trehalose, inulin, melezitose, stach, 
glycogen, xylitol, D-lyxose, D-fucose, L-fucose, D-arabitol, L-arabitol, 2-keto-gluconate, 5-keto-gluconate. 
a
Strains are all Propionibacterium acnes except for PG 2-4, which is a Propionibacterium granulosum; asterisks mark P. acnes recA type II strains, all others were shown to belong to type 
I; grey shading indicates sugars used to distinguish between type I and type II strains. 
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Table 2.- Enzymatic activities as measured with the API ZYM system of Propionibacterium strains 
from mucosa of the human stomach. 
 
Strain
a
 
Enzymatic activity
b
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PA 1-1 0 0 0 15 10 10 0 0 
PA 1-2 0 0 0 20 20 0 0 0 
PA 1-3* 0 0 0 0 0 5 0 0 
PA 1-4 0 0 0 10 10 10 0 0 
PA 1-5* 5 0 0 35 30 2.5 0 0 
PA 2-1 0 0 0 15 15 10 0 0 
PA 2-2 2.5 0 0 30 30 10 15 10 
PA 2-3 0 0 0 15 2.5 15 10 15 
PG 2-4
b
 35 10 2.5 40 35 0 2.5 0 
PA 3-1 2.5 2.5 2.5 30 10 0 0 0 
PA 3-2 5 2.5 0 20 0 0 0 0 
PA 5-2 0 0 0 20 15 2.5 0 0 
PA 6-1 0 0 0 20 15 2.5 0 0 
PA 6-2 5 0 2.5 40 15 10 0 0 
PA 6-3 0 0 0 15 5 5 0 0 
PA 6-4* 10 0 0 40 15 10 20 0 
PA 6-5 0 0 0 10 5 5 0 0 
PA 7-1 5 0 2.5 40 30 10 0 0 
PA 7-2 0 0 0 5 5 2.5 0 0 
PA 7-3 2.5 0 0 35 30 10 0 0 
PA 8-1 5 0 0 40 40 20 10 15 
PA 8-2* 0 0 0 2.5 5 2.5 0 0 
PA 8-3 15 0 0 40 40 15 15 15 
PA 10-1 5 0 0 35 10 10 0 0 
         
 
Leucine arylamidase, valine arylamidase, cysteine arylamidase, lipase (C14), trypsin, α-quimiotrypsin, -galactosidase, -
galatosidase, -glucosidase, β-glucuronidase, and -fucosidase activities were never detected. 
a
Strains are all P. acnes except for PG 2-4, which is a P. granulosum; asterisks mark P. acnes recA type II strains, all others 
were shown to belong to type I. 
b
Units of activity are expressed as nmol of substrate hydrolyzed under the assay conditions. 
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Table 3.- Antibiotic resistance susceptibility profiles of representative strains of Propionibacterium strains from mucosa of the human 
stomach. MIC (g mL-1) 
 
 
Key of antibiotics: AM: ampicillim; PC: penicillin G; GM: gentamicin; KM: kanamycin; SM: streptomycin; NM: neomycin; TC: tetracycline; EM: erythromycin; 
CL: clindamycin; CM: chloramphenicol; VA: vancomycin; VI: virginiamycin; LZ: linezolid; TM: trimethoprim; CI: ciprofloxacin; RI: rifampicin. 
a
Strains are all P. acnes except for PG 2-4, which is a P. granulosum; asterisk marks P. acnes recA type II strains, all others were shown to belong to type I. 
Straina 
Antibiotic 
AM PC GM KM SM NM TC EM CL CM VA VI LZ TM CI RI 
                 
PA 1-1 0.03 0.03 1 4 1 0.5 0.25 0.016 0.06 1 0.5 0.12 0.5 2 1 0.12 
PA 1-3* 0.03 0.03 2 8 16 0.5 0.25 0.12 1 4 2 0.5 1 1 0.5 0.12 
PA 2-1 0.06 0.03 2 8 4 1 0.5 0.03 0.06 0.5 0.5 0.12 0.5 1 0.5 0.12 
PA 2-2 0.12 0.06 2 16 8 2 0.5 0.06 0.12 1 0.5 0.06 1 8 2 0.12 
PG 2-4 0.03 0.12 1 8 4 0.5 0.5 0.016 0.03 0.5 0.5 0.06 0.5 32 0.5 0.12 
PA 3-1 0.06 0.06 2 2 2 0.5 0.5 0.03 0.06 1 0.5 0.06 0.5 2 1 0.12 
PA 3-2 0.12 2 0.5 2 2 0.5 0.25 0.12 0.25 4 1 0.25 1 1 0.25 0.12 
PA 5-2 0.03 0.03 2 4 1 0.5 1 0.016 0.06 1 0.5 0.06 1 4 1 0.12 
PA 6-1 0.03 0.03 2 4 1 1 0.5 0.03 0.06 1 0.5 0.06 0.5 2 1 0.12 
PA 6-3 0.25 0.12 4 16 8 2 0.5 0.06 0.12 1 1 0.12 0.5 4 1 0.12 
PA 7-1 0.03 0.03 2 4 0.5 2 0.5 0.016 0.03 0.25 0.5 0.06 0.12 0.25 0.5 0.12 
PA 7-3 0.03 0.03 2 8 4 1 0.5 0.25 0.06 1 0.5 0.06 0.5 2 2 0.12 
PA 8-2* 0.03 0.03 2 8 0.5 0.5 0.12 0.016 0.03 0.12 0.25 0.06 0.25 2 1 0.12 
PA 10-1 0.03 0.03 2 8 2 1 0.25 0.016 0.06 0.5 0.5 0.06 0.25 1 1 0.12 
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Table 4.- Phenotypic, virulence-associated activities of Propionibacterium strains 
isolated from the mucosa of the human stomach. 
 
Strain
a
 
Activity
b
 
Haemolytic DNase Lipolytic Protelytic 
     
PA 1-1 - - ++ + 
PA 1-2 - - ++ (+) 
PA 1-3* - - Ng - 
PA 1-4 - - ++ - 
PA 1-5* - - - - 
PA 2-1 - - + - 
PA 2-2 - - + + 
PA 2-3 - - + (+) 
PG 2-4 - - + - 
PA 3-1 - - + - 
PA 3-2 - - ++ - 
PA 5-2 - - ++ - 
PA 6-1 - - ++ - 
PA 6-2 - - ++ - 
PA 6-3 (+) - ++ + 
PA 6-4* - - Ng - 
PA 6-5 - - ++ - 
PA 7-1 - - ++ (+) 
PA 7-2 - - ++ - 
PA 7-3 - - ++ - 
PA 8-1 (+) - ++ - 
PA 8-2* - - ++ - 
PA 8-3 - - + - 
PA 10-1 - - ++ (+) 
     
 
a
Strains are all P. acnes except for PG 2-4, which is a P. granulosum; asterisks mark P. acnes recA type 
II strains, all others were shown to belong to type I. 
b
Number of crosses is related to the level of activity; in parenthesis, weak activities. 
Ng, no growth observed. 
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